<DOC>
	<DOCNO>NCT01466738</DOCNO>
	<brief_summary>The purpose study evaluate safety clinical characteristic quantity human rhinovirus Type 16 ( HRV-16 ) healthy volunteer . This source HRV-16 subsequently use viral challenge study new compound intend treat respiratory disease .</brief_summary>
	<brief_title>A Study Human Rhinovirus Type 16 ( HRV-16 ) Following Administration Nose Healthy Adult Volunteers</brief_title>
	<detailed_description>This open-label study participant know investigational substance test . Participants inoculate nose HRV-16 evaluate occurrence cold symptoms indicator . There 3 phase : screening phase , HRV-16 infection phase , follow-up phase . The dose virus test study previously use challenge study . The total length participation study 4 week . Participant safety monitor .</detailed_description>
	<criteria>Demonstrate understanding study sign inform consent form prior studyrelated procedure Healthy clinically significant abnormality determine medical history Women must neither pregnant lactating ( produce breast milk ) negative urine pregnancy test Screening Visit 1 Women childbearing potential men must agree use adequate birth control measure ( determine investigator ) must agree continue use measure plan pregnancy Day 6 visit Men must agree donate sperm study Day 6 visit Have document serumneutralizing antibody titer &gt; 2fold dilution HRV16 blood sample within approximately 40 day Screening Visit 2 Live family member care elderly , infant , small child ( eg , nursing home day care provider ) , live someone chronic lung disease , premature infant , immunocompromised individual Require prescription overthecounter medication regular basis ( 3 time per week ) , except contraceptive preparation , hormone replacement therapy , topical acne medication Have history chronic disease Investigator believe clinically significant Have history chronic headache ( eg frequent migraine , cluster headache ) 3 headache per week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Rhinovirus</keyword>
	<keyword>Cold virus</keyword>
	<keyword>HRV-16</keyword>
</DOC>